AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,066,231 | -24.2% | 458,810 | -22.0% | 0.01% | -25.0% |
Q2 2023 | $42,275,957 | +5.7% | 588,310 | -9.2% | 0.01% | 0.0% |
Q1 2023 | $39,979,619 | -39.3% | 648,178 | -24.1% | 0.01% | -50.0% |
Q4 2022 | $65,841,716 | +23.3% | 853,646 | -28.7% | 0.02% | +14.3% |
Q3 2022 | $53,395,000 | +135.8% | 1,196,672 | +102.4% | 0.01% | +133.3% |
Q2 2022 | $22,646,000 | -7.7% | 591,304 | -0.3% | 0.01% | +50.0% |
Q1 2022 | $24,548,000 | -51.4% | 593,100 | -55.6% | 0.00% | +300.0% |
Q4 2021 | $50,508,000 | +117.1% | 1,336,888 | +89.4% | 0.00% | -75.0% |
Q3 2021 | $23,269,000 | -9.6% | 705,992 | +85.0% | 0.00% | 0.0% |
Q2 2021 | $25,750,000 | +50.7% | 381,717 | +26.5% | 0.00% | +33.3% |
Q1 2021 | $17,086,000 | -70.0% | 301,767 | -56.9% | 0.00% | -40.0% |
Q4 2020 | $57,012,000 | +58.5% | 699,776 | +38.6% | 0.01% | -37.5% |
Q3 2020 | $35,979,000 | -2.0% | 504,966 | +13.2% | 0.01% | -11.1% |
Q2 2020 | $36,702,000 | -10.8% | 446,060 | -36.2% | 0.01% | -30.8% |
Q1 2020 | $41,147,000 | -69.8% | 699,422 | -47.0% | 0.01% | -66.7% |
Q4 2019 | $136,369,000 | +654.9% | 1,319,354 | +47.8% | 0.04% | +457.1% |
Q3 2019 | $18,065,000 | -50.8% | 892,544 | -37.3% | 0.01% | +75.0% |
Q2 2019 | $36,684,000 | +770.5% | 1,424,578 | +381.0% | 0.00% | +33.3% |
Q1 2019 | $4,214,000 | +2910.0% | 296,146 | +492.5% | 0.00% | – |
Q4 2018 | $140,000 | +12.9% | 49,984 | +29.5% | 0.00% | – |
Q2 2018 | $124,000 | +195.2% | 38,600 | +122.9% | 0.00% | – |
Q1 2018 | $42,000 | -93.8% | 17,318 | -85.7% | 0.00% | – |
Q4 2017 | $677,000 | +260.1% | 120,795 | +252.8% | 0.00% | – |
Q2 2017 | $188,000 | +64.9% | 34,238 | +157.4% | 0.00% | – |
Q1 2016 | $114,000 | – | 13,302 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |